DE3269188D1 - Vaccine for hepatitis - Google Patents

Vaccine for hepatitis

Info

Publication number
DE3269188D1
DE3269188D1 DE8282304601T DE3269188T DE3269188D1 DE 3269188 D1 DE3269188 D1 DE 3269188D1 DE 8282304601 T DE8282304601 T DE 8282304601T DE 3269188 T DE3269188 T DE 3269188T DE 3269188 D1 DE3269188 D1 DE 3269188D1
Authority
DE
Germany
Prior art keywords
hepatitis
vaccine
albumin
polymerized
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282304601T
Other languages
English (en)
Inventor
Girish Narmadashankara Vyas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Application granted granted Critical
Publication of DE3269188D1 publication Critical patent/DE3269188D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE8282304601T 1981-09-04 1982-09-01 Vaccine for hepatitis Expired DE3269188D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29945281A 1981-09-04 1981-09-04

Publications (1)

Publication Number Publication Date
DE3269188D1 true DE3269188D1 (en) 1986-03-27

Family

ID=23154848

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282304601T Expired DE3269188D1 (en) 1981-09-04 1982-09-01 Vaccine for hepatitis

Country Status (6)

Country Link
EP (1) EP0074248B1 (de)
JP (1) JPS5883631A (de)
AT (1) ATE18007T1 (de)
AU (1) AU554859B2 (de)
DE (1) DE3269188D1 (de)
ES (1) ES8404188A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248565B (it) * 1991-06-27 1995-01-19 Erba Carlo Spa Anticorpi policlonali anti-irudina e loro utilizzo per la identificazione, l`immunopurificazione e la determinazione quantitativa dell`uridina.
US6719975B1 (en) 1991-06-27 2004-04-13 Farmitalia Carlo Erba S.R.L. Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin
CA2184132C (en) * 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
US6682746B2 (en) 1995-09-21 2004-01-27 Kristina J. Hennessy Adjuvanted vaccine which is substantially free of non-host albumin
ES2330904B1 (es) 2005-09-21 2010-09-23 Fundacio Centre De Recerca En Sanitat Animal Polinucleotidos de haemophilus parasuis y su uso.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046871A (en) * 1975-04-08 1977-09-06 Ortho Diagnostics Inc. Compositions and serological methods including bovine serum albumin polymers

Also Published As

Publication number Publication date
EP0074248A3 (en) 1983-09-28
JPS5883631A (ja) 1983-05-19
ES515472A0 (es) 1984-04-16
AU8778582A (en) 1983-03-10
EP0074248B1 (de) 1986-02-19
AU554859B2 (en) 1986-09-04
ES8404188A1 (es) 1984-04-16
ATE18007T1 (de) 1986-03-15
EP0074248A2 (de) 1983-03-16

Similar Documents

Publication Publication Date Title
EP0200412A3 (en) Method of conferring immunotolerance to a specific antigen
DE69304521D1 (de) Impfstoff Adjuvans
MY110665A (en) Combined vaccines comprising hepatitis b surface antigen and other antigen
ZA938203B (en) Urease-based vaccine against helicobacter infection
NO172745C (no) Analogifremgangsmaate for fremstilling av et herpes simplex viruspolypeptid egnet for anvendelse i en vaksinasjonsprosess
DK155915C (da) Fremgangsmaade til fremstilling af pertussis-toksoid til anvendelse i vacciner
DE3485873D1 (en) Herpes simplex virus subunitimpfstoff.
IL82235A (en) Immunogen complexes, their preparation and vaccines comprising them
NO873993L (no) Fremgangsmaate for fremstilling av fluorid- og calsiumpreparat med langvarig frigjoerelse.
ES2036179T3 (es) Procedimiento para preparar monohidrato de hidrocloruro de (s)-(-)-1-propil-2',6'-pipecoloxilidida.
FR2348704A1 (fr) Procede de preparation d'un vaccin contre le virus de la rhinopneumonie equine et vaccin ainsi obtenu
DE3269188D1 (en) Vaccine for hepatitis
DK196687A (da) Kombineret vaccine, samt fremgangsmaade til fremstilling deraf
EP0290565A4 (de) Impfstoff, der zecken-antigene enthält.
IL79740A0 (en) Hepatitis vaccine
JPS51140245A (en) Solar heat collector and regenerator
EP0367302A3 (de) Verfahren zur Halbsynthese von menschlichem Insulin, dabei zu verwendende, vernetzte, wasserlösliche Achromobacter Protease I und Verfahren zu dessen Herstellung
AU7008687A (en) Improvements in and relating to vaccines
GB2200844B (en) Preparation of bordetella bronchiseptica strains useful as vaccines
PH25860A (en) Novel vaccines
PT69953A (en) Process for preparing a composition comprising a lyophilized herpes virus
BG41961A1 (en) Method for cultivating virus of haemorrhagic fever with knidney syndrome on cell cultures
Felfe et al. Trends in production of foot-and-mouth disease vaccine.
IE853251L (en) Vaccine with oil-enhanced antigenicity
IE860983L (en) Antigens related to envelope glycoprotein of the virus of¹aids

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee